Table 3 Characteristics of food addiction (FA) subjects (n = 400).

From: A case–control study investigating food addiction in Parkinson patients

 

Without FA (n = 327)

With FA (n = 73)

p

Gender, n (% male)

206 (63.0)

34 (46.6)

0.01

Age (years), mean (SD)

67.9 (9.8)

65.8 (10.1)

0.10

BMI (kg/m2), mean (SD)

25.6 (4.2)

25.2 (3.8)

0.48

PD diagnosis, n (%)

151 (46.2)

49 (67.1)

0.001

Cumulative LEDD (mg/day), median [IQR]

0 [0; 450]

372 [0; 663]

0.002

Levodopa dose (mg/day), median [IQR]

0 [0; 300]

74 [0; 500]

0.008

DA medication, n (%)

73 (22.3)

28 (38.4)

0.004

DA dose (LEDD, mg/day), median [IQR]

0 [0; 0]

0 [0; 160]

0.007

Punding, n (%)

92 (28.1)

24 (32.9)

0.42

Compulsive buying, n (%)

13 (4.0)

9 (12.3)

0.009

Pathological gambling, n (%)

6 (1.8)

3 (4.1)

0.22

Hypersexuality, n (%)

8 (2.4)

2 (2.7)

1.00

HADS

HADS-anxiety score, mean (SD)

7.7 (4.0)

8.9 (3.7)

0.02

Anxiety cases, n (%)

72 (22.0)

27 (37.0)

0.007

HADS-depression score, mean (SD)

5.6 (3.8)

5.5 (3.8)

0.79

Depression cases, n (%)

34 (10.4)

8 (11.0)

0.89

BIS-11, mean (SD)

Total

55.7 (8.9)

57.7 (9.4)

0.09

Motor

17.1 (3.4)

17.5 (4.0)

0.46

Non-planning

22.7 (4.5)

23.1 (4.2)

0.45

Attentional

16.0 (3.3)

17.2 (3.6)

0.006

Food composition inducing craving, n (%)

High-sugar

12/16 (75.0)

44/62 (71.0)

1.00

High-fat

9/16 (56.2)

49/62 (79.0)

0.11

Chocolate

7 (2.1)

28 (38.4)

< 0.001

  1. Bold values indicate statistical significance (p < 0.05).
  2. BIS-11 Barratt impulsiveness scale, BMI body mass index, DA medication dopamine agonist medication, HADS hospital anxiety and depression scale, LEDD levodopa equivalent daily dose, PD Parkinson’s disease, SD standard deviation.